Brief: Shilpa Medicare Submits NDA To US FDA By Unicycive
04/09/2024 10:32
Sept 4 (Reuters) - Shilpa Medicare Ltd SHME.NS :
* SHILPA MEDICARE LTD - SUBMISSION OF NDA TO U.S. FDA BY
UNICYCIVE
* SHILPA MEDICARE- SUBMISSION OF NDA TO US FDA FOR
OXYLANTHANUM
CARBONATE
Source text for Eikon: ID:nNSE2SHYNS
Further company coverage: SHME.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shilpa Medicare
See all newsBrief: Shilpa Medicare Q2 Consol Net Profit INR 791.8 Million
Brief: Shilpa Medicare Says USFDA Conducts Surveillance Inspection At Shilpa Medicare Unit
Brief: Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization
India's Shilpa Medicare gains on approval for OERIS
Brief: Shilpa Medicare Initiates Voluntary Recall Of 27,923 Pemetrexed Injection Vials In Us On July 29, 2026